Skip to content

The relationship between the risk of metabolic syndrome and body composition in heavyweight athletes

The relationship between the risk of metabolic syndrome and body composition in heavyweight athletes - The cardiometabolic risk in heavyweight athletes and the change of these risk by dietary counseling intervention.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000020501
Enrollment
60
Registered
2016-01-09
Start date
2013-09-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiometabolic disease, Metabolic syndrome

Interventions

Interventional period is about 12 weeks. Some measurements and collecting food records for participants are conducted at baseline. Individual nutritional problems are identified and personal target ar

Sponsors

Waseda University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Heavyweight athletes without disease under treatment and with usual training status during this research period

Exclusion criteria

Exclusion criteria: The person without usualy training by injury and defect The person with an electrical magnetic or mechanically operated device in/on their body (i.e. cardiac pacemakers, bone growth stimulation device and cochlear implants hearing aids) The person with an intracranial aneurysm clips that operator cannot identify a non-magnetic apparatus The person without participating other interventional study

Design outcomes

Primary

MeasureTime frame
Blood biochemical parameter at baseline and after 12 weeks intervention

Secondary

MeasureTime frame
Parameters related to body composition including cross-sectional area of abdominal fat and muscle and percent body fat at baseline and after 12 weeks intervention

Countries

Japan

Contacts

Public ContactHiroko Murata

Waseda University Graduate school of Sport Sciences

hiromura@toki.waseda.jp04-2947-6778

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026